Charleston, SC -- (SBWIRE) -- 09/11/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Homex Development Corp. (ADR) (NYSE:HXM), Lloyds Banking Group PLC (ADR) (NYSE:LYG), A.P. Pharma, Inc. (OTCBB:APPA), Merrimack Pharmaceuticals Inc (NASDAQ:MACK).
Homex Development Corp. (ADR) (NYSE:HXM) ended its recent business day with the loss of -2.41% and closed at the price of $2.43 after opening at $2.52. The stock traded during its last trading session with the total volume of 1,992,063 shares, as compared to its average volume of 1.93 million shares. Desarrolladora Homex, S.A.B. de C.V., a vertically integrated home development company, engages in the development, construction, and sale of affordable entry-level, middle-income, and tourism housing in Mexico, as well as affordable entry-level housing in Brazil.
Has HXM Found The Bottom and Ready To Move Up? Find Out Here
Lloyds Banking Group PLC (ADR) (NYSE:LYG) remained among the day advancers and traded with volume of 2,010,769 shares in the last session, as compared to average volume of 2.83 million shares. In comparison with 52 week range of $2.29 - $4.94, it faced lowest price of $4.88 during the last trading session whereas its day highest price was $4.94. The company’s total market capitalization is $88.02 billion, along with 17.85 million shares outstanding. Lloyds Banking Group plc provides banking and financial services to personal, commercial, and corporate customers in the United Kingdom and internationally.
For How Long LYG’s Gloss will Attract Investors? Find out via this report
A.P. Pharma, Inc. (OTCBB:APPA) showed 1.95 million shares in volume during the last trading session, while the average trading volume remained 561,767.00 shares. The stock kicked off its trading session at $0.37 and closed at $0.360 after declining -7.69%. A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
Why Should Investors Buy APPA After the Recent Fall? Just Go Here and Find Out
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock traded during its last trading session with the total traded volume of 1,931,104 shares versus its average volume of 2.12 million shares. The company opened its trade at the price of $4.19 and its closing price was $4.07 after losing -2.75% for the day. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)